NCT03983382 - A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients | Biotech Hunter

Enrollment

190

Participants

Timeline

Start Date

March 22, 2019

Primary Completion Date

September 18, 2023

Study Completion Date

March 31, 2026

Conditions

Breast Cancer

Interventions

DIAGNOSTIC_TEST

Left Ventricular Ejection Fraction

LVEF assessment at baseline, 6 months, and 12 months

Trial Locations (8)

Memorial Sloan Kettering Cancer Center, New York

Memorial Sloan Kettering Westchester (Consent and Follow-up), Harrison

Memorial Sloan Kettering Nassau (Consent and Follow-up), Rockville Centre

Memorial Sloan Kettering Cancer Center @ Commack (Consent and Follow up), Commack

Hartford Healthcare Cancer Institute @ Hartford Hospital (Data collection only), Hartford

Memorial Sloan Kettering Cancer Center @ BaskingRidge (Consent and follow-up only), Basking Ridge

Memorial Sloan Kettering Monmouth (Consent and Follow up), Middletown

Memorial Sloan Kettering Bergen (Consent and follow-up only), Montvale

All Listed Sponsors

lead

Memorial Sloan Kettering Cancer Center

OTHER